Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is
voluntarily recalling certain lots of CUBICIN® (daptomycin for
injection) to the user level due to the potential presence of glass
particulate matter in vials produced by a contract manufacturer.
for Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter investment picks